VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,477,278 | +85.3% | 188,200 | +98.1% | 0.08% | +68.1% |
| Q1 2023 | $2,416,800 | +1073.2% | 95,000 | +434.4% | 0.05% | +1466.7% |
| Q2 2022 | $206,000 | -69.0% | 17,777 | -50.6% | 0.00% | -62.5% |
| Q1 2022 | $665,000 | -6.7% | 36,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $713,000 | +20.4% | 36,000 | 0.0% | 0.01% | +14.3% |
| Q3 2021 | $592,000 | – | 36,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 944,092 | $15,530,000 | 5.65% |
| Ally Bridge Group (NY) LLC | 904,978 | $14,887,000 | 4.38% |
| COMMODORE CAPITAL LP | 667,674 | $10,983,000 | 2.90% |
| FRAZIER MANAGEMENT LLC | 1,505,200 | $24,761,000 | 1.98% |
| Logos Global Management LP | 1,500,000 | $24,675,000 | 1.78% |
| Ghost Tree Capital, LLC | 350,000 | $5,758,000 | 1.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,078 | $1,745,000 | 0.99% |
| Vivo Capital, LLC | 1,300,000 | $21,385,000 | 0.96% |
| ACUTA CAPITAL PARTNERS, LLC | 135,807 | $2,234,000 | 0.79% |
| BVF INC/IL | 804,126 | $13,228,000 | 0.52% |